 Jordan Jacobelli
Concepts (265)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes | 23 | 2024 | 1996 | 3.490 |
Why?
| | Cell Movement | 19 | 2024 | 962 | 3.130 |
Why?
| | Nonmuscle Myosin Type IIA | 5 | 2016 | 8 | 1.960 |
Why?
| | Actins | 7 | 2022 | 426 | 1.480 |
Why?
| | Microfilament Proteins | 2 | 2022 | 133 | 1.190 |
Why?
| | Cell Adhesion Molecules | 4 | 2022 | 179 | 1.190 |
Why?
| | Autoimmunity | 5 | 2021 | 908 | 1.150 |
Why?
| | Phosphoproteins | 2 | 2022 | 332 | 1.070 |
Why?
| | Lymphocyte Activation | 12 | 2022 | 1136 | 0.980 |
Why?
| | Transendothelial and Transepithelial Migration | 2 | 2017 | 30 | 0.920 |
Why?
| | Actin-Related Protein 2-3 Complex | 2 | 2021 | 9 | 0.840 |
Why?
| | Lymph Nodes | 4 | 2018 | 494 | 0.830 |
Why?
| | Cell Adhesion | 9 | 2017 | 448 | 0.720 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2022 | 911 | 0.660 |
Why?
| | Antigen-Presenting Cells | 7 | 2021 | 158 | 0.640 |
Why?
| | Molecular Imaging | 1 | 2018 | 55 | 0.540 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2018 | 134 | 0.520 |
Why?
| | Interleukin-4 | 1 | 2018 | 212 | 0.510 |
Why?
| | Cell Communication | 7 | 2014 | 306 | 0.510 |
Why?
| | Immunological Synapses | 5 | 2022 | 17 | 0.480 |
Why?
| | Leukemia, Experimental | 1 | 2016 | 28 | 0.480 |
Why?
| | Mice | 26 | 2024 | 17969 | 0.480 |
Why?
| | Animals | 34 | 2024 | 37328 | 0.440 |
Why?
| | Dendritic Cells | 6 | 2018 | 487 | 0.430 |
Why?
| | Diabetes Mellitus, Type 1 | 7 | 2021 | 3793 | 0.420 |
Why?
| | Cell Nucleus | 2 | 2016 | 607 | 0.420 |
Why?
| | Peripheral Tolerance | 1 | 2013 | 15 | 0.390 |
Why?
| | Gene Expression | 1 | 2018 | 1490 | 0.380 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 288 | 0.380 |
Why?
| | Islets of Langerhans | 4 | 2021 | 809 | 0.380 |
Why?
| | Polymerization | 3 | 2022 | 126 | 0.370 |
Why?
| | Myosin Type II | 3 | 2024 | 19 | 0.360 |
Why?
| | Inflammation | 2 | 2020 | 2840 | 0.350 |
Why?
| | Intercellular Adhesion Molecule-1 | 3 | 2009 | 142 | 0.310 |
Why?
| | Mice, Inbred C57BL | 8 | 2024 | 5866 | 0.310 |
Why?
| | B-Lymphocytes | 4 | 2021 | 857 | 0.310 |
Why?
| | CD11c Antigen | 3 | 2019 | 40 | 0.290 |
Why?
| | Phagocytes | 2 | 2021 | 83 | 0.280 |
Why?
| | Receptors, Antigen, T-Cell | 6 | 2014 | 716 | 0.270 |
Why?
| | Signal Transduction | 12 | 2024 | 5116 | 0.270 |
Why?
| | Mice, Knockout | 5 | 2020 | 3042 | 0.260 |
Why?
| | Cytoskeletal Proteins | 2 | 2022 | 154 | 0.250 |
Why?
| | Antigens | 4 | 2021 | 349 | 0.240 |
Why?
| | Histocompatibility Antigens Class II | 3 | 2015 | 367 | 0.240 |
Why?
| | Disease Models, Animal | 1 | 2016 | 4414 | 0.230 |
Why?
| | Receptor, EphB4 | 1 | 2024 | 33 | 0.220 |
Why?
| | Ephrin-B2 | 1 | 2024 | 45 | 0.220 |
Why?
| | Molecular Motor Proteins | 1 | 2004 | 46 | 0.210 |
Why?
| | Ovalbumin | 2 | 2015 | 194 | 0.210 |
Why?
| | Brain | 1 | 2016 | 2857 | 0.200 |
Why?
| | Killer Cells, Natural | 6 | 2004 | 467 | 0.200 |
Why?
| | Myosin Heavy Chains | 1 | 2004 | 179 | 0.190 |
Why?
| | Endothelial Cells | 2 | 2020 | 816 | 0.180 |
Why?
| | Lysophospholipids | 1 | 2022 | 73 | 0.180 |
Why?
| | c-Mer Tyrosine Kinase | 1 | 2021 | 38 | 0.180 |
Why?
| | Cell Line | 4 | 2020 | 2863 | 0.170 |
Why?
| | Immune Tolerance | 2 | 2021 | 373 | 0.170 |
Why?
| | Mice, Transgenic | 5 | 2021 | 2165 | 0.170 |
Why?
| | Vaccines, Conjugate | 1 | 2021 | 63 | 0.170 |
Why?
| | Actin Cytoskeleton | 1 | 2021 | 101 | 0.170 |
Why?
| | Phosphorylation | 8 | 2014 | 1753 | 0.160 |
Why?
| | Lymphatic System | 1 | 2020 | 15 | 0.160 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2021 | 127 | 0.160 |
Why?
| | Pneumococcal Infections | 1 | 2021 | 108 | 0.160 |
Why?
| | Pneumococcal Vaccines | 1 | 2021 | 138 | 0.160 |
Why?
| | Adaptive Immunity | 1 | 2021 | 170 | 0.160 |
Why?
| | Streptococcus pneumoniae | 1 | 2021 | 167 | 0.150 |
Why?
| | Head and Neck Neoplasms | 1 | 2024 | 557 | 0.150 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2017 | 1111 | 0.140 |
Why?
| | Antigen Presentation | 2 | 2013 | 213 | 0.140 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2021 | 195 | 0.140 |
Why?
| | Germinal Center | 1 | 2018 | 65 | 0.130 |
Why?
| | Integrin alpha4 | 1 | 2017 | 7 | 0.130 |
Why?
| | Genes, Reporter | 1 | 2018 | 270 | 0.130 |
Why?
| | Cells, Cultured | 7 | 2016 | 4149 | 0.130 |
Why?
| | T-Lymphocyte Subsets | 2 | 2012 | 413 | 0.130 |
Why?
| | Chemotaxis | 1 | 2017 | 122 | 0.120 |
Why?
| | Cellular Microenvironment | 2 | 2014 | 91 | 0.120 |
Why?
| | Protein-Tyrosine Kinases | 5 | 2003 | 428 | 0.120 |
Why?
| | Mononuclear Phagocyte System | 1 | 2016 | 10 | 0.120 |
Why?
| | Nuclear Lamina | 1 | 2016 | 9 | 0.120 |
Why?
| | Microscopy | 1 | 2018 | 156 | 0.120 |
Why?
| | Cytoskeleton | 3 | 2022 | 192 | 0.120 |
Why?
| | Spleen | 2 | 2015 | 512 | 0.120 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2016 | 70 | 0.120 |
Why?
| | Integrin beta1 | 3 | 2000 | 25 | 0.120 |
Why?
| | Antigens, Differentiation, B-Lymphocyte | 1 | 2015 | 37 | 0.120 |
Why?
| | HIV-1 | 1 | 2021 | 882 | 0.110 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 2 | 2013 | 67 | 0.110 |
Why?
| | Humans | 23 | 2024 | 141284 | 0.100 |
Why?
| | Immunoblotting | 2 | 2016 | 308 | 0.100 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 768 | 0.100 |
Why?
| | Gene Knockout Techniques | 1 | 2013 | 117 | 0.100 |
Why?
| | Alum Compounds | 1 | 2013 | 27 | 0.100 |
Why?
| | Integrins | 3 | 2003 | 92 | 0.100 |
Why?
| | Chemokines | 2 | 2006 | 223 | 0.100 |
Why?
| | Mice, Inbred NOD | 3 | 2021 | 599 | 0.100 |
Why?
| | Muramidase | 1 | 2012 | 66 | 0.100 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2012 | 101 | 0.090 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2013 | 68 | 0.090 |
Why?
| | Software | 1 | 2018 | 675 | 0.090 |
Why?
| | Vaccination | 1 | 2021 | 1468 | 0.090 |
Why?
| | Flow Cytometry | 1 | 2016 | 1182 | 0.090 |
Why?
| | Autoantigens | 1 | 2014 | 424 | 0.090 |
Why?
| | Adjuvants, Immunologic | 1 | 2013 | 238 | 0.090 |
Why?
| | Immune System | 1 | 2013 | 183 | 0.090 |
Why?
| | Tyrosine | 5 | 2004 | 229 | 0.090 |
Why?
| | Immunoglobulin E | 1 | 2012 | 319 | 0.090 |
Why?
| | Immunity, Cellular | 1 | 2013 | 266 | 0.080 |
Why?
| | Neutrophils | 1 | 2016 | 1113 | 0.080 |
Why?
| | Interleukin-2 | 2 | 2004 | 448 | 0.080 |
Why?
| | Cell Differentiation | 1 | 2018 | 1983 | 0.080 |
Why?
| | Cell Surface Extensions | 1 | 2008 | 14 | 0.070 |
Why?
| | Cell Shape | 1 | 2008 | 57 | 0.070 |
Why?
| | Transfection | 2 | 2009 | 932 | 0.070 |
Why?
| | GTP Phosphohydrolases | 1 | 2008 | 94 | 0.070 |
Why?
| | Microscopy, Confocal | 1 | 2009 | 324 | 0.070 |
Why?
| | Receptors, Chemokine | 2 | 2006 | 48 | 0.070 |
Why?
| | Cysteine Endopeptidases | 1 | 2007 | 74 | 0.060 |
Why?
| | Apoptosis | 1 | 2016 | 2487 | 0.060 |
Why?
| | Protozoan Proteins | 1 | 2007 | 88 | 0.060 |
Why?
| | Neoplasms | 1 | 2022 | 2731 | 0.060 |
Why?
| | Protease Inhibitors | 1 | 2007 | 102 | 0.060 |
Why?
| | Multigene Family | 1 | 2007 | 202 | 0.060 |
Why?
| | Receptors, IgG | 2 | 2004 | 73 | 0.060 |
Why?
| | DNA | 1 | 2013 | 1440 | 0.060 |
Why?
| | Intracellular Fluid | 1 | 2005 | 25 | 0.060 |
Why?
| | Extracellular Fluid | 1 | 2005 | 35 | 0.060 |
Why?
| | Intercellular Junctions | 1 | 2005 | 38 | 0.060 |
Why?
| | Membrane Microdomains | 1 | 2005 | 34 | 0.060 |
Why?
| | Aging | 1 | 2015 | 1919 | 0.050 |
Why?
| | Wiskott-Aldrich Syndrome | 1 | 2004 | 4 | 0.050 |
Why?
| | Epitopes | 1 | 2005 | 476 | 0.050 |
Why?
| | rac GTP-Binding Proteins | 1 | 2003 | 34 | 0.050 |
Why?
| | Interferon-gamma | 2 | 2014 | 784 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2007 | 503 | 0.050 |
Why?
| | Lung | 1 | 2016 | 4051 | 0.050 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2024 | 213 | 0.050 |
Why?
| | Integrin beta Chains | 1 | 2002 | 7 | 0.050 |
Why?
| | Vitronectin | 1 | 2002 | 7 | 0.050 |
Why?
| | Endothelium | 1 | 2003 | 119 | 0.050 |
Why?
| | Candida albicans | 1 | 2002 | 57 | 0.050 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2022 | 28 | 0.050 |
Why?
| | Female | 9 | 2021 | 75814 | 0.050 |
Why?
| | Receptors, Lysophosphatidic Acid | 1 | 2022 | 35 | 0.050 |
Why?
| | Male | 5 | 2021 | 70140 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2024 | 674 | 0.050 |
Why?
| | Chemokine CCL21 | 2 | 2015 | 13 | 0.050 |
Why?
| | Receptors, CCR7 | 2 | 2015 | 31 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2000 | 301 | 0.040 |
Why?
| | CD11 Antigens | 1 | 2021 | 30 | 0.040 |
Why?
| | Inducible T-Cell Co-Stimulator Protein | 1 | 2021 | 9 | 0.040 |
Why?
| | Immunogenicity, Vaccine | 1 | 2021 | 34 | 0.040 |
Why?
| | Neoplasms, Experimental | 1 | 2021 | 174 | 0.040 |
Why?
| | Antibodies, Bacterial | 1 | 2021 | 145 | 0.040 |
Why?
| | Asthma | 1 | 2012 | 1911 | 0.040 |
Why?
| | Receptors, Fibronectin | 1 | 2000 | 6 | 0.040 |
Why?
| | Proteins | 2 | 2004 | 1007 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2024 | 711 | 0.040 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2000 | 55 | 0.040 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2000 | 221 | 0.040 |
Why?
| | Adenine | 1 | 2021 | 335 | 0.040 |
Why?
| | Piperazines | 1 | 2021 | 375 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2000 | 268 | 0.040 |
Why?
| | Enzyme Activation | 4 | 2002 | 784 | 0.040 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 1998 | 45 | 0.040 |
Why?
| | Carcinoma, Transitional Cell | 1 | 1999 | 70 | 0.040 |
Why?
| | Myeloid Cells | 1 | 2019 | 147 | 0.040 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 167 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 2000 | 320 | 0.030 |
Why?
| | Focal Adhesion Kinase 2 | 3 | 2003 | 4 | 0.030 |
Why?
| | Cell Membrane | 2 | 2012 | 704 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 3502 | 0.030 |
Why?
| | Lamin Type A | 1 | 2016 | 47 | 0.030 |
Why?
| | Urinary Bladder Neoplasms | 1 | 1999 | 255 | 0.030 |
Why?
| | Mice, Nude | 2 | 2013 | 700 | 0.030 |
Why?
| | Chemokine CCL19 | 1 | 2015 | 6 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 1998 | 436 | 0.030 |
Why?
| | Cathepsins | 1 | 2015 | 24 | 0.030 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 2 | 2006 | 27 | 0.030 |
Why?
| | Cadaver | 1 | 2016 | 305 | 0.030 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2015 | 81 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2015 | 316 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3577 | 0.020 |
Why?
| | Receptor Cross-Talk | 1 | 2013 | 21 | 0.020 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2012 | 51 | 0.020 |
Why?
| | Cytokinesis | 1 | 2013 | 50 | 0.020 |
Why?
| | Cytokines | 1 | 2000 | 2079 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2012 | 219 | 0.020 |
Why?
| | Aerosols | 1 | 2012 | 177 | 0.020 |
Why?
| | Cell Separation | 1 | 2012 | 309 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2808 | 0.020 |
Why?
| | Antigens, CD | 2 | 2006 | 537 | 0.020 |
Why?
| | Lipid Bilayers | 1 | 2012 | 102 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2012 | 594 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 415 | 0.020 |
Why?
| | Fluorescence | 1 | 2010 | 161 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2008 | 115 | 0.020 |
Why?
| | Septins | 1 | 2008 | 43 | 0.020 |
Why?
| | Myosins | 1 | 2008 | 137 | 0.020 |
Why?
| | Autoantibodies | 1 | 2015 | 1466 | 0.020 |
Why?
| | Trypanosoma cruzi | 1 | 2007 | 40 | 0.020 |
Why?
| | RNA Interference | 1 | 2008 | 465 | 0.020 |
Why?
| | Chemokines, CC | 1 | 2006 | 34 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2008 | 487 | 0.020 |
Why?
| | Down-Regulation | 1 | 2008 | 636 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2021 | 11216 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2006 | 305 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2006 | 404 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2600 | 0.010 |
Why?
| | Adult | 2 | 2021 | 39319 | 0.010 |
Why?
| | Ligands | 1 | 2006 | 665 | 0.010 |
Why?
| | Wiskott-Aldrich Syndrome Protein | 1 | 2004 | 4 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 13727 | 0.010 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2004 | 21 | 0.010 |
Why?
| | Chromosomes, Human, X | 1 | 2004 | 77 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2004 | 288 | 0.010 |
Why?
| | Integrin alpha4beta1 | 1 | 2003 | 8 | 0.010 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2003 | 41 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 2146 | 0.010 |
Why?
| | Cell Line, Transformed | 1 | 2003 | 145 | 0.010 |
Why?
| | Receptors, Vitronectin | 1 | 2002 | 5 | 0.010 |
Why?
| | Integrin alphaV | 1 | 2002 | 5 | 0.010 |
Why?
| | Integrin beta3 | 1 | 2002 | 13 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2911 | 0.010 |
Why?
| | Proline | 1 | 2003 | 80 | 0.010 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2002 | 35 | 0.010 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2002 | 30 | 0.010 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2002 | 37 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2004 | 1059 | 0.010 |
Why?
| | Thrombocytopenia | 1 | 2004 | 206 | 0.010 |
Why?
| | Antibodies | 1 | 2004 | 399 | 0.010 |
Why?
| | Antigens, Bacterial | 1 | 2002 | 124 | 0.010 |
Why?
| | Mutagenesis | 1 | 2002 | 183 | 0.010 |
Why?
| | Adolescent | 1 | 2021 | 22116 | 0.010 |
Why?
| | Protein Binding | 1 | 2007 | 2233 | 0.010 |
Why?
| | Antibody-Dependent Cell Cytotoxicity | 1 | 2000 | 20 | 0.010 |
Why?
| | CD18 Antigens | 1 | 2000 | 22 | 0.010 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 2000 | 37 | 0.010 |
Why?
| | MAP Kinase Kinase 3 | 1 | 2000 | 6 | 0.010 |
Why?
| | Enzyme Induction | 1 | 2000 | 88 | 0.010 |
Why?
| | p21-Activated Kinases | 1 | 2000 | 13 | 0.010 |
Why?
| | K562 Cells | 1 | 2000 | 95 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 130 | 0.010 |
Why?
| | Fibronectins | 1 | 2000 | 135 | 0.010 |
Why?
| | Middle Aged | 1 | 2021 | 34658 | 0.010 |
Why?
| | Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 1998 | 11 | 0.010 |
Why?
| | Shc Signaling Adaptor Proteins | 1 | 1998 | 11 | 0.010 |
Why?
| | GRB2 Adaptor Protein | 1 | 1998 | 12 | 0.010 |
Why?
| | Retroviridae | 1 | 1999 | 103 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 272 | 0.010 |
Why?
| | Transplantation, Heterologous | 1 | 1999 | 194 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 1998 | 182 | 0.010 |
Why?
| | Cross-Linking Reagents | 1 | 1998 | 208 | 0.010 |
Why?
| | Genetic Vectors | 1 | 1999 | 336 | 0.010 |
Why?
| | Histocompatibility Antigens Class I | 1 | 1999 | 207 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1999 | 959 | 0.010 |
Why?
| | Genetic Therapy | 1 | 1999 | 315 | 0.010 |
Why?
| | Endothelium, Vascular | 1 | 2002 | 943 | 0.010 |
Why?
| | Immunotherapy | 1 | 1999 | 641 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 1999 | 1486 | 0.010 |
Why?
| | RNA, Messenger | 1 | 1999 | 2815 | 0.010 |
Why?
| | Infant | 1 | 2004 | 9820 | 0.000 |
Why?
| | Child, Preschool | 1 | 2004 | 11511 | 0.000 |
Why?
| | Child | 1 | 2004 | 22390 | 0.000 |
Why?
|
|
Jacobelli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|